BDTX · Black Diamond Therapeutics, Inc. · Documents
$1.94
+0.05 (+2.65%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$107.44M
Shares
57.45M
Volume · Oct 5
839.14K
Avg daily vol (3M)
681.51K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-05 | — | |
| 10-Q | 2026-08-05 | 2026-06-30 | |
| 8-K | 2026-06-29 | 2026-06-26 | |
| 8-K | 2026-05-21 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-29 | 2026-06-26 | |
| 8-K | 2026-03-16 | — | |
| 10-K | 2026-03-16 | 2025-12-31 | |
| 8-K | 2025-12-03 | — | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-12 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-05-12 | — | |
| DEF 14A | 2025-04-18 | 2025-06-12 | |
| 8-K | 2025-03-19 | 2025-03-18 | |
| 8-K | 2025-03-06 | — | |
| 10-K | 2025-03-06 | 2024-12-31 | |
| 8-K | 2024-11-05 | — | |
| 10-Q | 2024-11-05 | 2024-09-30 | |
| 8-K | 2024-10-07 | — | |
| 8-K | 2024-09-23 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-08-06 | — | |
| 8-K | 2024-06-06 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-24 | 2024-06-06 | |
| 8-K | 2024-04-11 | 2024-04-10 | |
| 8-K | 2024-03-12 | — | |
| 10-K | 2024-03-12 | 2023-12-31 | |
| 8-K | 2024-01-18 | 2024-01-17 | |
| 8-K | 2024-01-04 | — | |
| 8-K | 2023-12-13 | — | |
| 8-K | 2023-11-06 | — | |
| 10-Q | 2023-11-06 | 2023-09-30 | |
| 8-K | 2023-09-18 | 2023-09-15 | |
| 8-K | 2023-08-11 | — | |
| 10-Q | 2023-08-11 | 2023-06-30 | |
| 8-K | 2023-06-30 | 2023-06-29 | |
| 8-K | 2023-06-27 | — | |
| 8-K | 2023-05-16 | — | |
| 8-K | 2023-05-09 | — | |
| 10-Q | 2023-05-09 | 2023-03-31 | |
| DEF 14A | 2023-04-04 | 2023-05-16 | |
| 10-K | 2023-03-09 | 2022-12-31 | |
| 8-K | 2023-03-09 | — |
Showing 1–50 of 94 filings